FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087142841> ?p ?o ?g. }

• W3087142841 endingPage "4315" @default.
• W3087142841 startingPage "4315" @default.
• W3087142841 abstract "Type 2 diabetes mellitus (T2DM) is associated with lipid metabolism disorder, particularly elevated plasma levels of non-esterified free fatty acids (NEFFA) and an increased cardiovascular disease risk, such as essential hypertension (H). The plasma unbalance of saturated fatty acid (SFA)/polyunsaturated fatty acid (PUFA) ratio is a likely contributor, but the mechanisms involved are not clearly elucidated. The aim of this study is to explore the association between plasma SFA/PUFA ratio and the clusters of cardiometabolic syndrome (CMS), including the atherogenic biomarkers, inflammatory status, feeding patterns, and physical activity in people with T2DM with or without essential hypertension. The study was conducted on 784 adult male and female participants, aged between 30 and 50 years, and divided into 3 groups: 100 T2DM without hypertension (D); 368 T2DM with hypertension (DM); and 316 hypertensive participants without T2DM (H). All Participants were phenotyped regarding CMS clusters according to the NCEP/ATPIII criteria. Insulin resistance was assessed by Homeostasis model assessment (HOMA model). Metabolic, atherogenic, and inflammatory parameters were analyzed by biochemical methods; NEFFA by microfluorimetry; SFA, PUFA-n6 and PUFA-n3 by gas phase chromatography. Dietary lipids and physical activity were analyzed through the use of validated questionnaires. The clusters of CMS were found in all groups. Dyslipidemia was correlated with accretion NEFFA levels in all groups, but more accentuated in the DH group (r = +0.77; p < 0.001). Similarly, plasma PUFA/SFA ratio and PUFA-3 level was lower, concomitantly with a higher plasma ApoB100/ApoA1 (p < 0.001), lipoprotein (a), homocysteine (p < 0.001), and pro-inflammatory cytokines (TNFα, IL-6, IL1-β) in the DH group. Likewise, the depletion of PUFA-n3/PUFA-n6 ratio is associated with the decrease of omega 3-DHA (docosahexaenoic acid) and omega 3-EPA (eicosapentaenoic acid) (p < 0.001). It appears that the PUFAs-n3 ratio modulates cardiometabolic risk, inflammatory state and atherogenic biomarkers. The plasma unbalanced ratio of SFA/PUFA reflects dietary fatty acids intake. The contribution of dietary lipids is undisputed. Nutritional recommendations are required to determine the fatty acids ratio (saturated and unsaturated) provided in the diet." @default.
• W3087142841 created "2020-09-25" @default.
• W3087142841 creator A5001370498 @default.
• W3087142841 creator A5013307798 @default.
• W3087142841 creator A5015584836 @default.
• W3087142841 creator A5051835084 @default.
• W3087142841 date "2020-09-20" @default.
• W3087142841 modified "2023-09-29" @default.
• W3087142841 title "Lipid Profile Modulates Cardiometabolic Risk Biomarkers Including Hypertension in People with Type-2 Diabetes: A Focus on Unbalanced Ratio of Plasma Polyunsaturated/Saturated Fatty Acids" @default.
• W3087142841 cites W1502502282 @default.
• W3087142841 cites W1643585163 @default.
• W3087142841 cites W1890547526 @default.
• W3087142841 cites W1957376790 @default.
• W3087142841 cites W1964249945 @default.
• W3087142841 cites W1964948935 @default.
• W3087142841 cites W1972408356 @default.
• W3087142841 cites W1973057380 @default.
• W3087142841 cites W1978258186 @default.
• W3087142841 cites W1978730983 @default.
• W3087142841 cites W1985473826 @default.
• W3087142841 cites W1988649393 @default.
• W3087142841 cites W1992074621 @default.
• W3087142841 cites W1996414762 @default.
• W3087142841 cites W2000638935 @default.
• W3087142841 cites W2001170097 @default.
• W3087142841 cites W2005040360 @default.
• W3087142841 cites W2006342148 @default.
• W3087142841 cites W2012898950 @default.
• W3087142841 cites W2017982229 @default.
• W3087142841 cites W2021405559 @default.
• W3087142841 cites W2022647504 @default.
• W3087142841 cites W2022665890 @default.
• W3087142841 cites W2028068170 @default.
• W3087142841 cites W2034512415 @default.
• W3087142841 cites W2035400847 @default.
• W3087142841 cites W2036564112 @default.
• W3087142841 cites W2038686627 @default.
• W3087142841 cites W2040043100 @default.
• W3087142841 cites W2052207090 @default.
• W3087142841 cites W2053770058 @default.
• W3087142841 cites W2054200483 @default.
• W3087142841 cites W2055502736 @default.
• W3087142841 cites W2063259781 @default.
• W3087142841 cites W2073081893 @default.
• W3087142841 cites W2083277816 @default.
• W3087142841 cites W2087245486 @default.
• W3087142841 cites W2091530119 @default.
• W3087142841 cites W2091768907 @default.
• W3087142841 cites W2095989530 @default.
• W3087142841 cites W2097400680 @default.
• W3087142841 cites W2097984233 @default.
• W3087142841 cites W2102323857 @default.
• W3087142841 cites W2111645882 @default.
• W3087142841 cites W2114364424 @default.
• W3087142841 cites W2117383112 @default.
• W3087142841 cites W2123074911 @default.
• W3087142841 cites W2127056938 @default.
• W3087142841 cites W2132197535 @default.
• W3087142841 cites W2133275623 @default.
• W3087142841 cites W2136604885 @default.
• W3087142841 cites W2143024959 @default.
• W3087142841 cites W2144380582 @default.
• W3087142841 cites W2151604950 @default.
• W3087142841 cites W2159595657 @default.
• W3087142841 cites W2159687614 @default.
• W3087142841 cites W2168526937 @default.
• W3087142841 cites W2169632752 @default.
• W3087142841 cites W2176487670 @default.
• W3087142841 cites W2184058676 @default.
• W3087142841 cites W2226488179 @default.
• W3087142841 cites W2260015110 @default.
• W3087142841 cites W2329674237 @default.
• W3087142841 cites W2333084676 @default.
• W3087142841 cites W2339876638 @default.
• W3087142841 cites W2339959472 @default.
• W3087142841 cites W2340906654 @default.
• W3087142841 cites W2413888528 @default.
• W3087142841 cites W2416278394 @default.
• W3087142841 cites W2483228038 @default.
• W3087142841 cites W2526681881 @default.
• W3087142841 cites W2530844910 @default.
• W3087142841 cites W2555497316 @default.
• W3087142841 cites W2808168384 @default.
• W3087142841 cites W3044857195 @default.
• W3087142841 cites W4238251256 @default.
• W3087142841 cites W4376595709 @default.
• W3087142841 doi "https://doi.org/10.3390/molecules25184315" @default.
• W3087142841 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7570813" @default.
• W3087142841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32962299" @default.
• W3087142841 hasPublicationYear "2020" @default.
• W3087142841 type Work @default.
• W3087142841 sameAs 3087142841 @default.
• W3087142841 citedByCount "6" @default.
• W3087142841 countsByYear W30871428412021 @default.
• W3087142841 countsByYear W30871428412022 @default.
• W3087142841 countsByYear W30871428412023 @default.
• W3087142841 crossrefType "journal-article" @default.
• W3087142841 hasAuthorship W3087142841A5001370498 @default.

• next